Medicine & Health

WashU biomedical engineers in Ismael Seáñez’s lab are evaluating which strategies and treatments are the most effective for spinal cord injuries.

A tool developed by WashU Medicine researchers can accurately distinguish among several major neurodegenerative diseases — including Alzheimer’s, Parkinson’s, frontotemporal dementia and dementia with Lewy bodies — as well as detect when these conditions overlap, potentially improving early diagnosis, monitoring and treatment.

Anne M. Drewry, MD, a nationally recognized leader in critical care medicine, has been installed as the inaugural Llorin-Roa Professor of Anesthesiology at WashU Medicine.

Biologists in WashU Arts & Sciences discovered that pH conditions can dramatically change how bacteria respond to antibiotics.

Behavioral science researchers at WashU have gathered evidence on the benefits of using a Bayesian statistical framework for replicating research.

A cost-effective screening tool developed by WashU Medicine researchers allows for broader genomic testing for patients with peripheral neuropathy of unknown cause.

The largest gift in WashU history, from the Bursky Family Foundation, will advance the School of Public Health’s vision in a post-pandemic world.

A new study led by WashU Medicine researchers shows that, for blood cancer patients, a genetically engineered stem cell transplant helps prevent toxic side effects and potentially improves the effectiveness of therapies.

A WashU Medicine-led clinical trial has found that a personalized vaccine to treat glioblastoma appears to increase recurrence-free survival in a subset of patients after surgery.